期刊文献+

羟喜树碱对人肾上腺皮质癌SW-13细胞生长增殖的影响 被引量:1

Influence of Hydroxycamptothecine on the Growth and Proliferation of Human Adrenoeortical Carcinoma Cell Line SW-13
下载PDF
导出
摘要 目的观察羟喜树碱对人肾上腺皮质癌SW-13细胞生长增殖的影响。方法体外培养人肾上腺皮质癌SW-13细胞,随机分为干预组和对照组,干预组加入羟喜树碱使其终浓度为0.8μg/ml,对照组不加羟喜树碱,分别培养48 h后,采用台盼蓝拒染法观察羟喜树碱对SW-13细胞生长增殖的影响。结果光镜下可见干预组SW-13细胞数减少,死亡细胞数较多,干预组活细胞率明显低于对照组(P<0.05)。结论羟喜树碱可能具有抑制人肾上腺皮质癌SW-13细胞增殖并促进其死亡的作用。 Objective To observe the effect of hydroxycamptothecine ( HCPT) on the growth and proliferation of human adrenoeortical carcinoma cell line SW-13.Methods Human adrenoeortical carcinoma cells SW-13 cultured in vitro were randomly divided into two groups ,the 0.8ug/ml HCPT intervention group and negative control group . SW-13 cells were exposed to hydroxycamptothecine for 48 hours.The effect of hydroxycamptothecine on the growth and proliferation of human adrenoeortical carcinoma cell line SW-13 was observed by trypan blue exclusion staining . Results The number of SW-13 cells decreased in the intervention group by light microscope ,the number of dead cells increased significantly .The live cells in the intervention group were more than those in the control group (P〈0.05). Conclusion Hydroxycamptothecine may suppress the proliferation of human adrenoeortical carcinoma cell line SW -13 and promote the death of SW-13 cells.
出处 《广西医学》 CAS 2013年第10期1273-1274,1287,共3页 Guangxi Medical Journal
基金 国家自然科学基金(81060220 2010jjB40066) 广西卫生厅科研主题(Z2012269)
关键词 肾上腺皮质癌 羟喜树碱 人肾上腺皮质癌SW-13细胞 台盼蓝拒染法 Adrenoeortical carcinoma Hydroxycamptothecine Human adrenoeortical carcinoma cell line SW-13 Trypan blue exclusion staining
  • 相关文献

参考文献9

二级参考文献50

共引文献33

同被引文献8

  • 1李志春,桂立辉.利用Excel实现对实验对象随机分组的应用[J].毒理学杂志,2005,19(3):235-236. 被引量:24
  • 2Berruti A,Baudin E, Gelderblom H, et al. Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up[J]. Ann Oncol,2012,23(Suppl 7):131 -138.
  • 3Fassnacht M,Terzolo M, Allolio B, et al. Combination chem- otherapy in advanced adrenocortical carcinoma[ J]. N Engl J Med,2012,366(23) :2 189 -2 197.
  • 4Makeyev Y, Muggia F, Rajan A, et al. DNA Topoisomerases and Cancer[ M]. Springer New York ,2012:245 - 277.
  • 5Hollingshead MG, Dykes DJ. Anticancer drug development guide [ M ]. Springer,2004 : 125 - 152.
  • 6Houghton PJ, Morton CL, Tucker C, et al. The pediatric pre- clinical testing program: description of models and early testing results [ J ]. Pediatr Blood Cancer, 2007,49 ( 7 ) : 928 - 940.
  • 7Pommier Y. Topoisomerase Ⅰ inhibitors:camptothecins and beyond[ J]. Nat Rev Cancer,2006,6 (10) :789 - 802.
  • 8腊蕾,班武,饶进军,吴曙光.化疗药羟喜树碱诱导Wnt信号通路抑制剂DKK-1的表达作用[J].南方医科大学学报,2008,28(4):623-626. 被引量:5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部